Skip to content

Registry of MIUS for Urolithiasis (ReMIUS-U)

Registry of Minimally Invasive Urology Society for Urolithiasis Patients

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06394908
Acronym
ReMIUS-U
Enrollment
10000
Registered
2024-05-01
Start date
2023-05-10
Completion date
2030-05-31
Last updated
2025-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Surgical Procedure, Stone, Kidney, Stone Ureter, Urolithiasis

Keywords

Prospective studies, Registries, Urolithiasis

Brief summary

The purpose of this registry is to collect data on patients who have undergone minimally invasive treatments for urinary system stone disease, including percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), and flexible ureterorenoscopy (F-URS).

Detailed description

In this project, the Minimally Invasive Urology Association urolithiasis study group aimed to collect the data of adult and pediatric urinary system stone patients treated with PCNL, SWL, URS, and F-URS in a non-randomized, observational, and prospective manner. The registry was to be conducted multi-center in Turkey. In this project, Excel files were created and shared via Google Drive with the responsible physicians at the centers to be included in the study. Each parameter was prepared in an explanatory manner and can be readily filled out by physicians familiar with these methods. The ability to examine and modify existing data will be restricted to the worker and the database administrator. Patients' identities will not be revealed in the registry. The collected data are summarized in three sections under the major headings below; 1. Demographics and preoperative information; Patient, disease, and treatment method demographic data, such as age, gender, height, weight, previous diseases, medications used, location, size, and hardness of urinary tract stones, the side of the stone, and the methods used for diagnosis, will be prospectively recorded for patients whose consent was obtained. 2. Data during the operation; The duration of the operation as well as the devices and methods utilized will be recorded. 3. In the postoperative period, post-treatment findings, such as stone-free status and post-treatment complications, will be documented. A separate application to the ethics committee will be submitted for each study on the subject that will be created in the future from the multi-center, prospectively recorded data pool and on the subject that will be investigated.

Interventions

None listed

Sponsors

Samsun Education and Research Hospital
CollaboratorOTHER
Gazi University
CollaboratorOTHER
Koç University
CollaboratorOTHER
Baskent University
CollaboratorOTHER
Cukurova University
CollaboratorOTHER
Ondokuz Mayıs University
CollaboratorOTHER
Muğla Sıtkı Koçman University
CollaboratorOTHER
Necmettin Erbakan University
CollaboratorOTHER
Alanya Alaaddin Keykubat University
CollaboratorOTHER
Dokuz Eylul University
CollaboratorOTHER
Hitit University
CollaboratorOTHER
Marmara University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* To have a medical indication for urolithiasis * Complete data of treatment and follow-up course * Patients with consent * Patients \> 18 years-old * Patients \< 18 years-old

Exclusion criteria

* Missing data * Patients without consent * Not to have a medical indication for urolithiasis treatment * To have a contraindication for urolithiasis treatment

Design outcomes

Primary

MeasureTime frameDescription
Operative durations of each treatment technique (PCNL, SWL, URS, F-URS)Operation/procedure dayThe duration of the operation time
Operative radiation dosage of each treatment technique (PCNL, SWL, URS, F-URS)Operation/procedure dayX-ray dosage
Operative results of each treatment technique (PCNL, SWL, URS, F-URS)Operation/procedure dayThe duration of the laser time
Postoperative resultsimmediately after procedurePostoperative estimated glomerular filtration rate (CKD Epidemiology Collaboration (CKD-EPI) equation) (mL/min/1.73 m2)
Rate of postoperative complicationup to 3 months, postoperativelyAbnormal clinical and laboratory findings that may be seen after surgery and require additional intervention, treatment, or follow-up
Follow-upup to 10 yearsFollow-up results of patients for recurrence of disease of residual stones, if any reoperation records.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026